Recombinant Single-Chain Antibody with the Trojan Peptide Penetratin Positioned in the Linker Region Enables Cargo Transfer Across the Blood–Brain Barrier
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recombinant Single-Chain Antibody with the Trojan Peptide Penetratin Positioned in the Linker Region Enables Cargo Transfer Across the Blood–Brain Barrier
Authors
Keywords
Antibody fragment, Cell-penetrating peptides, Brain delivery, Prion, Penetratin
Journal
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
Volume 169, Issue 1, Pages 159-169
Publisher
Springer Nature
Online
2012-11-17
DOI
10.1007/s12010-012-9962-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered antibody approaches for Alzheimer’s disease immunotherapy
- (2012) Remy Robert et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Whole protein and defined CD8+ and CD4+ peptides linked to penetratin targets both MHC class I and II antigen presentation pathways
- (2011) Dodie S Pouniotis et al. IMMUNOLOGY AND CELL BIOLOGY
- Specific Binding of the Pathogenic Prion Isoform: Development and Characterization of a Humanized Single-Chain Variable Antibody Fragment
- (2011) Nives Škrlj et al. PLoS One
- Molecular basis for specificity of nuclear import and prediction of nuclear localization
- (2010) Mary Marfori et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A Pharmacologically Active Monoclonal Antibody against the Human Melanocortin-4 Receptor: Effectiveness After Peripheral and Central Administration
- (2010) J. C. Peter et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Epitope mapping of a PrP(Sc)-specific monoclonal antibody: Identification of a novel C-terminally truncated prion fragment
- (2010) Miha Kosmač et al. MOLECULAR IMMUNOLOGY
- Tat Peptide Is Capable of Importing Large Nanoparticles Across Nuclear Membrane in Digitonin Permeabilized Cells
- (2009) Nitin Nitin et al. ANNALS OF BIOMEDICAL ENGINEERING
- Single-Chain Fv Antibody Fragments Retain Binding Properties of the Monoclonal Antibody Raised Against Peptide P1 of the Human Prion Protein
- (2009) Nives Škrlj et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Synthesis and Studies on Cell-Penetrating Peptides
- (2009) Jean-Remi Bertrand et al. BIOCONJUGATE CHEMISTRY
- Vaccine Approaches to Prevent and Treat Prion Infection
- (2009) Andreas Müller-Schiffmann et al. BIODRUGS
- Curative properties of antibodies against prion protein: A comparative in vitro study of monovalent fragments and divalent antibodies
- (2009) Coralie Alexandrenne et al. JOURNAL OF NEUROIMMUNOLOGY
- Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity
- (2009) Motohiro Horiuchi et al. VIROLOGY
- Antibody variable-region sequencing as a method for hybridoma cell-line authentication
- (2008) Simon Koren et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Delivery of peptides to the brain: Emphasis on therapeutic development
- (2008) William A. Banks BIOPOLYMERS
- Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
- (2008) Leah R Hanson et al. BMC NEUROSCIENCE
- An Antibody to the Aggregated Synthetic Prion Protein Peptide (PrP106-126) Selectively Recognizes Disease-Associated Prion Protein (PrPSc) from Human Brain Specimens
- (2008) Michael Jones et al. BRAIN PATHOLOGY
- A versatile bacterial expression vector based on the synthetic biology plasmid pSB1
- (2008) Nives Škrlj et al. PROTEIN EXPRESSION AND PURIFICATION
- Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein
- (2007) C. Avignolo et al. FASEB JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More